Examining how therapy for insomnia affects diabetes risk
Sleep for Health: A randomized clinical trial examining the effects of cognitive behavioral therapy for insomnia on diabetes risk
This study is looking at how a special online program to improve sleep can help people with prediabetes and insomnia lower their blood sugar levels and sleep better, so if you have these conditions, you might be able to join and see if better sleep can help prevent diabetes!
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Kaiser Foundation Research Institute NIH-funded |
| Lab location | 1 site (Oakland, UNITED STATES) |
| Project ID | NIH-11034056 on NIH RePORTER |
What this research studies
This research investigates the impact of cognitive behavioral therapy for insomnia (CBT-I) on individuals at risk of developing type 2 diabetes. Participants with prediabetes and insomnia will be randomly assigned to either receive CBT-I through a digital program or access a patient education website. The study aims to measure changes in glucose levels and sleep quality over time, providing insights into how improving sleep may help prevent diabetes. Assessments will occur at the start, after 10 weeks, and again at 32 weeks to evaluate the effectiveness of the intervention.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who have prediabetes and experience insomnia.
Not a fit: Patients who do not have prediabetes or insomnia may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a new, effective method for preventing the onset of type 2 diabetes in at-risk individuals.
How similar studies have performed: Previous research has shown promising results in using cognitive behavioral therapy to improve sleep and potentially reduce diabetes risk, indicating that this approach may be effective.
Where this research is happening
Oakland, UNITED STATES
- Kaiser Foundation Research Institute — Oakland, United States (Active)
Researchers
- Principal investigator: Leblanc, Erin S — Kaiser Foundation Research Institute
- Study coordinator: Leblanc, Erin S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.